HSTM:NGS-HealthStream Inc. (USD)

EQUITY | Health Information Services | Nasdaq Global Select

Last Closing

USD 28.02

Change

+0.13 (+0.47)%

Market Cap

USD 0.79B

Volume

0.19M

Analyst Target

USD 27.33
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

HealthStream Inc provides SaaS-based workforce development solutions for healthcare organizations. It provides HealthStream Workforce Solutions, HealthStream Patient Experience Solutions, and HealthStream Provider Solutions.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-05-30 )

Largest Industry Peers for Health Information Services

Symbol Name Price(Change) Market Cap
GEHC GE HealthCare Technologies Inc..

N/A

USD 33.49B
TEM Tempus AI, Inc. Class A Common..

N/A

USD 9.87B
HQY HealthEquity Inc

N/A

USD 7.83B
WAY Waystar Holding Corp. Common S..

N/A

USD 6.42B
BTSG BrightSpring Health Services, ..

N/A

USD 4.26B
PRVA Privia Health Group Inc

N/A

USD 2.79B
CERT Certara Inc

N/A

USD 1.94B
PINC Premier Inc

N/A

USD 1.93B
SDGR Schrodinger Inc

N/A

USD 1.57B
GDRX Goodrx Holdings Inc

N/A

USD 1.55B

ETFs Containing HSTM

N/A

Market Performance

  Market Performance vs. Industry/Classification (Health Information Services) Market Performance vs. Exchange (Nasdaq Global Select)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -11.89% 44% F 39% F
Dividend Return 0.19% 50% F 5% F
Total Return -11.69% 44% F 39% F
Trailing 12 Months  
Capital Gain 2.67% 80% B- 59% D-
Dividend Return 0.43% 50% F 9% A-
Total Return 3.11% 80% B- 55% F
Trailing 5 Years  
Capital Gain 23.00% 80% B- 57% F
Dividend Return 1.20% 40% F 2% F
Total Return 24.21% 80% B- 51% F
Average Annual (5 Year Horizon)  
Capital Gain 9.93% 74% C 67% D+
Dividend Return 10.11% 74% C 65% D
Total Return 0.17% 29% F 5% F
Risk Return Profile  
Volatility (Standard Deviation) 19.47% 96% N/A 77% C+
Risk Adjusted Return 51.91% 94% A 81% B-
Market Capitalization 0.79B 75% C 71% C-

Key Financial Ratios

  Ratio vs. Industry/Classification (Health Information Services) Ratio vs. Market (Nasdaq Global Select)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 134.60 68% 22%
Price/Book Ratio 2.34 42% 41%
Price / Cash Flow Ratio 14.74 33% 20%
Price/Free Cash Flow Ratio 12.22 39% 30%
Management Effectiveness  
Return on Equity 5.72% 91% 68%
Return on Invested Capital 4.71% 79% 65%
Return on Assets 2.63% 83% 75%
Debt to Equity Ratio N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior capital utilization

The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

Superior Dividend Growth

This stock has shown top quartile dividend growth in the previous 5 years compared to its sector

What to not like:
Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector